Blurb from my book:
Bob Fiddaman was prescribed Seroxat due to depression that was, in essence, due to work related problems.
What followed was a journey that took him through a tapering process of, what he believes to be, a highly addictive antidepressant.
Following almost two years of withdrawal, Fiddaman's new battle with the manufacturer of the drug, GlaxoSmithKline and the UK's medicine regulator, the MHRA, took him on a more frustrating journey than he ever could have imagined.
The name Bob Fiddaman has become synonymous throughout cyberspace. Google his name and you will find articles he has written, many of which have been republished by a vast army of fellow patient advocate...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
